Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Underlying pathophysiological mechanisms of irritable bowel syndrome (IBS), a common disorder characterized by abdominal pain associated to a change in stool consistency or frequency, include low-grade inflammation and intestinal microbiota changes. Few and disappointing data are available for prebiotics. A few controlled trials (RCTs) of probiotics are instead available with favourable effects, although most are limited by suboptimal design and small sample size. A recent report from the Rome foundation group included 32 RCTs of probiotics, most of which showed an overall modest improvement in symptoms, with the patients most benefitting from probiotics being those with predominant diarrhoea and those having a post-infectious IBS. A review focusing only on children with functional gastrointestinal disorders concluded that probiotics are more effective than placebo in the treatment of patients with abdominal pain-related functional gastrointestinal disorders, although no effect on constipation was evident. The role for probiotics in inflammatory bowel disease (IBD) appears logical: the endogenous intestinal microbiota plays a central role in their development, and various probiotics have been found effective in animal models of IBD. However, research in humans has been overall quite limited, and it would seem that after a phase of intense research in the first decade of this century, the pace has slowed down, with fewer clinical trials been published in the past 2-3 years. To summarize current evidence: no probiotic has proven successful in Crohn's disease. In ulcerative colitis, on the other hand, data are more promising, and a very recent meta-analysis, that included 23 randomized controlled trials, concluded that there is evidence of efficacy for the probiotic mixture VSL#3 in helping inducing and maintaining remission, as well as in maintaining remission in patients with pouchitis. It is fair to state that for both IBD and IBS, more well-designed, rigorous, randomized clinical trials must be performed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The interplay between the intestinal microbiota and the brain
Collins, S. M., Surette, M., & Bercik, P. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2876 · Cited by 1,611 · cited 1×
“, 2008); colonic faecal microbiota transplantation (DuPont, 2014) has been utilized; and it is quite conceivable that microbiota may interfere with additional factors involved in the pathophysiology of IBS (Collins et al., 2012; Johnson et al., 2011).”
BackgroundKassinen, A., Krogius-Kurikka, L., Mäkivuokko, H., Rinttilä, T., Paulin, L., Corander, J., Malinen, E., Apajalahti, J., & Palva, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.005 · Cited by 1,002
Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome
Saulnier, D. M., Riehle, K., Mistretta, T., Diaz, M., Mandal, D., Raza, S., Weidler, E. M., Qin, X., Coarfa, C., Milosavljevic, A., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.072 · Cited by 672
Ong, D. K., Mitchell, S. B., Barrett, J. S., Shepherd, S. J., Irving, P. M., Biesiekierski, J. R., Smith, S., Gibson, P. R., & Muir, J. G. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06370.x · Cited by 583 · cited 1×
“In fact, it has been shown that a diet high in fermentable carbohydrates elevated hydrogen gas in 15 patients with IBS as well as 15 health control patients (Ong et al., 2010).”
BackgroundSILK, D. B. A., DAVIS, A., VULEVIC, J., TZORTZIS, G., & GIBSON, G. R. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03911.x · Cited by 551
Sood, A., Midha, V., Makharia, G. K., Ahuja, V., Singal, D., Goswami, P., & Tandon, R. K. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.07.016 · Cited by 513 · cited 1×
“While the overall analysis of these RCTs showed significant benefit from the use of probiotics, the sub-analysis based on probiotic utilised documented such significant effect only for VSL#3 (Miele et al., 2009; Ng et al., 2010; Sood et al., 2009; Tursi et al., 2004, 2010).”
ResultTursi, A., Brandimarte, G., Papa, A., Giglio, A., Elisei, W., Giorgetti, G. M., Forti, G., Morini, S., Hassan, C., Pistoia, M. A., et al. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.218 · Cited by 489
Lindsay, J. O. (2006) · Gut · doi:10.1136/gut.2005.074971 · Cited by 471
Carroll, I. M., Ringel‐Kulka, T., Siddle, J. P., & Ringel, Y. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01891.x · Cited by 425 · cited 1×
“Alterations in the intestinal microbiota have been described in patients with IBS versus nonIBS populations have been reported (Carroll et al., 2012; Kassinen et al., 2007; Saulnier et al., 2011); the development of IBS after a gastro-intestinal infection is well documented (‘post-infectious IBS’) (Saps et al.”
BackgroundShen, J., Zuo, Z.-X., & Mao, A.-P. (2014) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000437495.30052.be · Cited by 364 · cited 2×
“A 2014 meta-analysis (Shen et al., 2014) included 23 randomized controlled trials (12 in UC, 4 in ‘pouchitis’ and 7 in CD, only 3 of them in children) published up to 2011, with a total of 1,763 participants.”
Method
Cited by
Microbial translocation and microbiome dysbiosis in HIV-associated immune activation
Zevin, A. S., McKinnon, L., Burgener, A., & Klatt, N. R. (2016) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000234 · Cited by 267
The influence of the gut microbiome on obesity, metabolic syndrome and gastrointestinal disease
Parekh, P. J., Balart, L. A., & Johnson, D. A. (2015) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2015.16 · Cited by 219
“To date, the available data for prebiotic use in IBS is limited and results are disappointing.(60)”
BackgroundLactobacillus reuteri DSM 17938 in the Treatment of Functional Abdominal Pain in Children: RCT Study
Jadrešin, O., Hojsak, I., Mišak, Z., Kekez, A. J., Trbojević, T., Ivković, L., & Kolaček, S. (2017) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001478 · Cited by 71
Shin, S. P., Choi, Y. M., Kim, W. H., Hong, S. P., Park, J.-M., Kim, J., Kwon, O., Lee, E. H., & Hahm, K. B. (2018) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.17-73 · Cited by 46
Metadata
- Authors
- Guandalini, S., Cernat, E., & Moscoso, D.
- Venue
- Beneficial Microbes
- Publisher
- Walter de Gruyter GmbH
- Published
- 2015-01-01
- Volume
- 6
- Issue
- 2
- Pages
- 209-217
- ISSN
- 1876-2883 (ISSN-L)
- 1876-2891
- OpenAlex
- W2112033983
- Cited by
- 36
- References
- 27
- FWCI
- 8.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children. https://app.cochat.ai/papers/10.3920/bm2014.0067
- The paper
- Guandalini, S., Cernat, E., & Moscoso, D. (2015). Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children. Beneficial Microbes. https://doi.org/10.3920/bm2014.0067
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.